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 factor – a toxic glycolipid that incorporated into adjuvant induces 
granulomas. Linkage with TLRs could not be demonstrated and 
so far experiments with Mincle-deficient mice showed discrepant 
results related to anti-bacterial resistance. Lugo-Villarino et al. (6) 
give an account on the importance of the M1 M2 polarization that 
occurs during M.tb infection. Under the early TH1 (IFNg) influ-
ence M1 macrophages become strongly bactericidal. This shifts to 
a late Th2 (IL4, 10) M2 response with Arginase 1 expression that 
inhibits nitric oxide production resulting in poor or weak bacte-
ricidal capacity and the appearance of foamy macrophages that 
allow intracellular bacillary growth. Guirado and Schlesinger (7) 
confirm the protective role of the Th1-induced M.tb granuloma 
with strong M1 mediated bactericidal kill. They rightly stress the 
importance of the microenvironment in and around the granulo-
mas that cause a variety of pulmonary pathologies in a single person 
and they acknowledge the changing dynamics between host and 
pathogen during the long course of the infection. They enumerate 
the various in vivo TB models, the in vitro efforts and the emergent 
in silico approaches whereby the complex granuloma response is 
being simplified by computer simulation.
Moore et al. (8) introduce visceral leishmaniasis a chronic 
tropical disease caused by the protozoan Leishmania donovani. In 
humans or mice host resistance is linked to efficient granuloma 
development. The murine model has several different character-
istics. After infection the parasites are ingested by liver Kupffer 
cells which together with invariant natural killer T cells recruit 
monocytes. Both infiltrated CD4+ and CD8+ T cells are needed 
for parasite clearance. By 4D intravital imaging free movement of 
intralesional T cells was observed. Parasite clearance proceeds with 
no residual pathology (necrosis, fibrosis). The innovative computer 
modeling is being employed to simulate the effector cell popula-
tions and predict regulator cytokine activity.
Lundy and Lukacs (9) review the helminth-induced granuloma-
tous schistosomiasis mansoni, where antigens secreted by the para-
site eggs induce perioval granulomas that protect the liver from toxic 
egg secretions. The initial Th1 type inflammation, with chronicity is 
modulated to a Th2 response that significantly reduces granuloma 
size but enhances liver fibrosis. Downmodulation is mediated by 
T regulatory and CD5+ B cells that induce apoptosis of CD4+ T 
cells. It is also systemic for unrelated immune systems which has 
implications for vaccinations, allergy, and autoimmunity. Hams 
et al. (10) discuss the host parasite relationship in murine schisto-
somiasis. The parasite needs perioval granuloma formation for the 
successful egg excretion from the host. Host granulomas shield the 
liver from toxic egg secretions. But the predominant Th2 response 
generates eosinophile rich granulomas and  excessive fibrous healing 
Granulomas (tubercles) were described by pathologists as the 
 hallmark of tuberculosis (TB), an ancient, often lethal disease. The 
discovery by Koch of the bacilli [Mycobacterium tuberculosis, (M.tb)] 
as the causative agent of the disease initiated research that established 
the paradigm of the protective but also tissue-destructive nature of 
the granulomas. These Reviews provide an update on research in 
granulomatous infections/diseases and describe a shift into a new 
paradigm: the role of the pathogen in host-pathogen interaction.
The protective nature of the granuloma is based on phagocy-
tosis and killing of the ingested pathogen driven by the innate and 
adaptive immune responses. On bacterial invasion the antigen 
presenting cells, macrophages via their pattern recognition recep-
tors recognize the pathogen associated molecular patterns of the 
pathogen and initiate the defensive inflammatory response. Itoh 
et al. (1) present evidence that in the Bead-PPD lung granuloma 
model the innate TLR9 and the Dll4 Notch systems cooperate not 
only in the early recognition of M.tb patterns but also in skewing 
the incipient adaptive immune response toward the Th17 inflam-
matory cell activity. Granuloma formation is reliant on chemokines, 
the low MW proteins that recruit leukocytes to the focus of irrita-
tion and activate them. In Stephen W. Chensue’s (2) laboratory the 
artificial granuloma model was established by means of antigen 
coated beads injected into Th1 or Th2 response-primed mice. The 
resulting lung granulomas showed the TH1 or Th 2 type cellular 
response. Chemokine receptor analysis of such granulomas showed 
lesion age-dependent heterogeneity of the response. It is suggested 
that chemokine’s could be targeted for therapeutic intervention.
Ehlers and Schaible (3) give an overview of the M.tb granu-
loma research and the host-pathogen interaction. The protective 
role in TB of the granuloma is asserted, but reflecting the recent 
view M.tb is described to exploit the lesion for its dispersal and 
propagation. At the chronic stage of the disease bacilli within the 
lesion are dormant and adapt to low oxygen, pH, and nutritional 
conditions. The pathogen-induced strong TH1 type inflammation 
causes pathology: caseation, cavitation that allow the escape of 
the bacilli to infect a new host. The authors make the intriguing 
suggestion to focus on suppression of the intensity of inflamma-
tion rather than devising new vaccination modes that maintain 
the inflammatory response. Shaler et al. (4) describe the stages of 
the M.tb granuloma development with the appearance within the 
lesions of the non-phagocytic macrophage derivatives: foam, epi-
thelioid, and giant cells. They take the negative view of the lesions 
because they contribute to bacillary persistence and based on the 
newly emerging zebra fish embryo model contend that granulomas 
may be dispensable. Lang (5) discusses the relevance of Mincle a C 
type lectin on macrophages that is the receptor for bacterial cord 
New perspectives on ancient granulomas
Dov L. Boros*
Department of Immunology and Microbiology, Wayne State University, School of Medicine, Detroit, MI, USA
*Correspondence: dboros@med.wayne.edu
Edited by:
Charles Dinarello, University of Colorado Health Sciences Center, USA
Keywords: pathogens, inflammation, granuloma, pathogen sequestration, pathogen protection, granuloma necrosis, pathogen dispersal
www.frontiersin.org November 2013 | Volume 4 | Article 345 | 1
Editorial
published: 15 November 2013
doi: 10.3389/fimmu.2013.00345
that cause portal hypertension and intestinal  bleedings. CD8+ T 
cells, B cells, and M2 type macrophages play a role in granuloma 
regulation. Egg antigens are also active at the innate response level: 
they suppress TLR triggered TNFalpha production by dendritic 
cells but activate the NLRP3 inflammasome with IL1beta produc-
tion. Proteomic analysis of egg antigens revealed over 1000 pro-
teins indicating the daunting task of assigning roles to fractions in 
inflammation or pathology.
The compiled Reviews show significant advances in granuloma 
research both in new methodologies and the emergence of new 
paradigm(s) in host-pathogen interaction. In the various mod-
els several contributors rightly reaffirm the essential protective 
role of the immune granulomatous response. However, in TB the 
 quandary of the strong T cell-mediated anti-bacterial inflamma-
tion vs. the  tissue-destructive pathological sequelae still remains 
unsolved. Similarly, in schistosomiasis there is no intervention that 
could prevent or reverse the strong fibrosis that replaces the perioval 
granuloma.
It is instructive to compare the various experimental models 
with pulmonary sarcoidosis, a granulomatous disease of humans 
with no known etiologic agent(s). Broos et al. (in review) survey 
the current literature that proves the immune basis of the disease. 
Clinical observations described innate responses with cytokine/
chemokine secretion, macrophage recruitment, and inflamma-
tory Th1/Th17 T helper lymphocyte participation in the granu-
lomatous response. The disease may spontaneously resolve or may 
progress to fibrosis, lung pathology and death. Regulatory T cells 
(Treg) are considered to restrain overt T helper cell activity and 
the extent of inflammation but if they are dysfunctional, disease 
progression occurs. Thus, the clinical picture closely resembles the 
experimental animal models. Further observations are needed to 
unravel Th-Treg interaction and the precise role of Treg before 
effective therapy can be devised.
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